HomeCompareLABD vs XYLD

LABD vs XYLD: Dividend Comparison 2026

LABD yields 5.79% · XYLD yields 11.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LABD wins by $3.4K in total portfolio value
10 years
LABD
LABD
● Live price
5.79%
Share price
$16.30
Annual div
$0.94
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.3K
Annual income
$837.60
Full LABD calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
11.20%
Share price
$38.36
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.9K
Annual income
$3,351.03
Full XYLD calculator →

Portfolio growth — LABD vs XYLD

📍 LABD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLABDXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LABD + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LABD pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LABD
Annual income on $10K today (after 15% tax)
$492.12/yr
After 10yr DRIP, annual income (after tax)
$711.96/yr
XYLD
Annual income on $10K today (after 15% tax)
$952.37/yr
After 10yr DRIP, annual income (after tax)
$2,848.38/yr
At 15% tax rate, XYLD beats the other by $2,136.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LABD + XYLD for your $10,000?

LABD: 50%XYLD: 50%
100% XYLD50/50100% LABD
Portfolio after 10yr
$27.6K
Annual income
$2,094.31/yr
Blended yield
7.59%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LABD buys
0
XYLD buys
0
No recent congressional trades found for LABD or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLABDXYLD
Forward yield5.79%11.20%
Annual dividend / share$0.94$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$29.3K$25.9K
Annual income after 10y$837.60$3,351.03
Total dividends collected$7.1K$20.2K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: LABD vs XYLD ($10,000, DRIP)

YearLABD PortfolioLABD Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$11,279$578.96$10,840$1,120.44+$439.00LABD
2$12,679$610.29$11,786$1,249.59+$893.00LABD
3$14,207$641.15$12,854$1,397.78+$1.4KLABD
4$15,873$671.45$14,063$1,568.33+$1.8KLABD
5$17,686$701.11$15,434$1,765.19+$2.3KLABD
6$19,654$730.05$16,995$1,993.14+$2.7KLABD
7$21,788$758.22$18,777$2,257.95+$3.0KLABD
8$24,098$785.55$20,818$2,566.58+$3.3KLABD
9$26,597$812.02$23,163$2,927.50+$3.4KLABD
10$29,297$837.60$25,865$3,351.03+$3.4KLABD

LABD vs XYLD: Complete Analysis 2026

LABDStock

The Direxion Daily S&P Biotech Bull and Bear 3X ETFs seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.

Full LABD Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this LABD vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LABD vs SCHDLABD vs JEPILABD vs OLABD vs KOLABD vs MAINLABD vs QYLDLABD vs JEPQLABD vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.